jama-pediatrics

name

jama-pediatrics

description

Use when targeting JAMA Pediatrics or deciding whether a child- or adolescent-health study fits this venue. Encodes the journal's fit, the pediatric clinical and population-research evidence bar, pediatric design and ethics requirements, reporting-guideline and trial-registration expectations, JAMA Network house style, official-submission re-check, and desk-reject heuristics. Venue-fit aid only, not clinical advice.

JAMA Pediatrics (jama-pediatrics)

Journal positioning

JAMA Pediatrics is a JAMA Network specialty journal for clinical and population research on the health of infants, children, and adolescents. It favors rigorous, practice- and policy-relevant work — randomized pediatric trials, large child-health cohorts and population studies, prevention and developmental research, and health- services analyses — with JAMA's emphasis on age-appropriate outcomes, adequate power, and direct relevance to child and adolescent care. Studies that simply extrapolate adult findings, small descriptive series, and work using adult-derived outcomes without pediatric validation are a weak fit. This skill is a fit / venue-selection / re-framing aid; it is not clinical or regulatory advice and does not replace the journal's current instructions for authors. Before submitting, re-check the live JAMA Pediatrics author instructions.

When to trigger

• The author names JAMA Pediatrics for a child- or adolescent-health clinical, developmental, or population study and wants a fit/framing check.
• A pediatric study must be re-framed around an age-appropriate, developmentally valid outcome for a child-health readership.
• The author is choosing between JAMA Pediatrics, JAMA, and a pediatric-subspecialty journal.
• The author needs the journal's pediatric-specific design, ethics (assent/parental consent), reporting-guideline, registration, and desk-reject expectations.

Scope & topic fit

• Randomized pediatric trials (therapeutic, behavioral, preventive, or vaccine) with age-appropriate primary outcomes, including pragmatic designs.
• Large child- and adolescent-health cohorts, birth cohorts, and population/registry studies with rigorous confounding control.
• Developmental, neurodevelopmental, growth, nutrition, and early-life-exposure studies with validated pediatric measures.
• Adolescent health, mental-health, injury-prevention, and child-maltreatment research with appropriate sensitivity and ethics.
• Pediatric health-services, quality, vaccine-policy, and disparities research.
• Systematic reviews and meta-analyses answering a focused child-health question.

Method & evidence bar

• Trials and studies must use age- and developmentally appropriate, validated outcome measures and be adequately powered; adult-derived endpoints need pediatric validation.
• The applicable reporting guideline and checklist are required: CONSORT for trials, STROBE for observational studies, PRISMA for systematic reviews; report stratification by age/developmental stage where relevant.
• Trials require prospective registration; registration number, protocol, and statistical-analysis plan are expected.
• Pediatric ethics must be explicit: IRB approval, parental/guardian permission, child assent appropriate to age, and protections for vulnerable populations (neonates, adolescents, maltreatment).
• Observational and exposure claims must address confounding, family clustering, and missing data; causal language must match the design.
• Long-term developmental outcomes need adequate follow-up and handling of attrition.

Structure & house style

• JAMA Network format with a structured abstract and a Key Points box; re-check current article types (Original Investigation, Brief Report, Research Letter, etc.) and limits on the live guide.
• The introduction frames a focused, child-health-relevant question; the discussion states the clinical, developmental, or policy implication plainly.
• Tables/figures follow JAMA Network statistical-reporting standards; CONSORT/STROBE flow diagrams and age-stratified results are expected where applicable.
• Supplements carry the protocol, SAP, consent/assent documentation summary, and additional analyses.

Official-submission checklist

• Before giving submission-ready advice, read ../../resources/source-basis.md and ../../resources/official-source-map.md; start from the ICMJE and JAMA Network anchors, then cite the current JAMA Pediatrics page you checked.
• Search the live site for "JAMA Pediatrics instructions for authors" and follow the current version.
• Re-check article types and word/reference/table limits, structured-abstract and Key Points format, and the JAMA Network statistical-reporting requirements.
• Confirm trial registration, the reporting checklist (CONSORT/STROBE/PRISMA), the data-sharing statement, and protocol/SAP submission.
• Re-check IRB/ethics, parental consent and child assent, vulnerable-population protections, ICMJE disclosures, funding, and AI-use disclosure.
• If the live official instructions conflict with this skill, the official instructions win.

Pre-submission self-check

• The study answers a child-/adolescent-health question with age-appropriate, validated outcomes.
• The primary outcome is prespecified and developmentally valid; the study is adequately powered, stratified by age where relevant.
• The correct reporting checklist (CONSORT/STROBE/PRISMA) is completed and attached.
• Trials are prospectively registered with the number in the manuscript; protocol/SAP provided.
• Pediatric ethics are explicit: IRB, parental consent, child assent, and vulnerable-population protections.
• ICMJE disclosures and a data-sharing statement are prepared; confounding and attrition are addressed.

Common desk-reject triggers

• Adult findings extrapolated to children, or adult-derived outcomes used without pediatric validation.
• Small descriptive pediatric series with no clear practice, developmental, or policy implication.
• Missing or inadequate assent/parental-consent and vulnerable-population protections.
• Observational analyses with unaddressed confounding/family clustering or overstated causal claims.
• Missing trial registration, protocol, or the required reporting checklist.
• Narrow pediatric-subspecialty interest better served by a subspecialty journal.

Re-routing decision

• Broadly practice-changing, top-tier pediatric trial → general medicine (jama / NEJM / The Lancet in the natural-science bundle).
• Adult internal-medicine relevance over pediatrics → jama-internal-medicine.
• Child/adolescent mental-health primary focus → jama-psychiatry / the-lancet-psychiatry.
• Pediatric neurological/developmental-neurology focus → jama-neurology / brain.
• Pediatric surgical or perioperative focus → jama-surgery.

Output format

[Fit] High / Medium / Low (one-line reason)
[Target] JAMA Pediatrics
[Specialty tags] <2–3 closest child-/adolescent-health topics>
[Study design / reporting guideline] <RCT-CONSORT / cohort-STROBE / review-PRISMA>
[Method/evidence] <does power, age-appropriate outcome, registration, and pediatric ethics clear the bar?>
[Top risk] <the single most likely reason for rejection>
[Official items to re-check] <article type / registration / checklist / assent-consent / ethics / disclosures>
[Re-route suggestion] <if not a fit, a better-matched venue>